Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Anaemia
Interventions: Daprodustat, Darbepoetin alfa, Iron therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 36
States / cities: Anaheim, California • Cerritos, California • Escondido, California + 31 more

Conditions: Premature Birth, Neurodevelopmental Disorders, Brain Development Abnormality, Brain Lesion
Interventions: MRI, Neurodevelopmental/Neuropsychological Assessment; Diagnostic Test
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: Up to 8 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alcohol Abuse
Interventions: Brief Alcohol Intervention (BAI), Substance-free Activity Session (SFAS), Relaxation Training (RT), Education Control; Behavioral · Other
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years to 29 Years
Enrollment: 525 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Asthma
Interventions: Tezepelumab, Placebo; Biological · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 5 Years to 11 Years
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 30
States / cities: Montgomery, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 26 more

Conditions: Depressive Disorder, Major
Interventions: Sertraline and Elzasonan Combination, Sertraline, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 4
States / cities: Beverly Hills, California • Norwich, Connecticut • New York, New York + 1 more

Conditions: Chronic Pain, Disability Physical
Interventions: Physical Therapy; Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: South Burlington, Vermont

Conditions: Post-Operative Pain
Interventions: Sufentanil NanoTab PCA System/15 mcg, morphine IV PCA; Drug
Lead sponsor: Talphera, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 16
States / cities: Florence, Alabama • Montgomery, Alabama • Sheffield, Alabama + 13 more

Conditions: Contraception, Contraceptive Behavior
Interventions: Contraceptive Decision Support Tool; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 786 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: San Francisco, California

Conditions: Acute Pain
Interventions: Individual audit feedback, Peer comparison feedback; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Asthma
Interventions: Placebo, Tiotropium low dose mcg, Tiotropium high dose; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 10
States / cities: Rolling Hills Estates, California • Denver, Colorado • North Dartmouth, Massachusetts + 7 more

Conditions: Osteoarthritis
Interventions: Home PT via web-based platform, Home PT via paper manual, outpatient PT; Other
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gulf War Syndrome
Interventions: Lactulose Breath Test, Rifaximin, Placebo; Procedure · Drug
Lead sponsor: Henry C. Lin, MD; Federal
Eligibility: 21 Years and older
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2009
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Vascular Access Complication
Interventions: AccuCath IV Catheter Device, Conventional IV Catheter Device; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gastroesophageal Reflux Disease (GERD), Heartburn, Indigestion
Interventions: Secretol, Nexium; Drug
Lead sponsor: Effexus Pharmaceutical; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: HEPA Air Cleaner, Sham HEPA Air Cleaner; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Total Knee Replacement
Interventions: Kneehab XP, Quadriceps TENS; Device
Lead sponsor: Theragen Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Chorioamnionitis
Interventions: Unasyn, Ampicillin/gentamicin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Epilepsy
Interventions: Compliance; Behavioral
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 16 Years to 99 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Traumatic Brain Injury, Post-Concussion Syndrome
Interventions: Interactive metronome; Behavioral
Lead sponsor: The Defense and Veterans Brain Injury Center; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), EPP2
Interventions: PORT-77, Placebo; Drug
Lead sponsor: Portal Therapeutics, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Huntington Beach, California • Cincinnati, Ohio

Conditions: Wound Complication, Complications; Cesarean Section
Interventions: Tissue Adhesive, Sterile strips; Device
Lead sponsor: Endeavor Health; Other
Eligibility: Female only
Enrollment: 504 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Chicago, Illinois • Evanston, Illinois • Highland Park, Illinois

Conditions: Fracture Mandible
Interventions: Stryker Hybrid, Erich; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Program Modality
Interventions: Livestream Modality (treatment), Live Modality (control); Other
Lead sponsor: Healthy Relationships California; Other
Eligibility: 18 Years and older
Enrollment: 255 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Leucadia, California

Conditions: Physical Activity, Health-related Fitness, Cognition, Screen Time
Interventions: Exergaming intervention group, Traditional physical activity comparison; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 4 Years to 5 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)

Childhood Outcomes of Preterm Brain Abnormalities

Behavioral Economic and Wellness-based Approaches for Reducing Alcohol Use and Consequences Among Emerging Adults

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

Physical Therapy to Treat Chronic Pain in Survivors of Trauma

A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain

Patient-Centered Support for Contraceptive Decision-Making

A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Home PT vs FORCE PT

Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health

Controlled Study of Kneehab XP for Patients Undergoing Total Knee Replacement

Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis

Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:

"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"

A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)

Tissue Adhesive vs. Sterile Strips After Cesarean Delivery

A Comparison of Stryker Hybrid Arch Bars

Evaluation Exploring How Course Modality Influences the Effectiveness of the R3 Academy for Couples

Home-Based Exergaming Intervention